NSE filing, NSE: SATKARTAR. Summary written from the filing by ALFA Finder's alert engine.
Sat Kartar Life Ltd: key numbers
- Share price
- ₹150.00
- Market cap
- ₹236.9 Cr
- Revenue (annual)
- ₹200.7 Cr
- Net profit (annual)
- ₹17.10 Cr
- P/E (TTM)
- 13.8×Sector 49.0×
- Promoter holding
- 63.49%
- FII holding
- 0.77%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sat Kartar Life Ltd
All →Sat Kartar Life Capacity Expansion: ₹1.25 Cr Investment
Sat Kartar Life plans a 10-bed Ayurveda hospital in Bengaluru, its first South India facility. Estimated investment is ₹1.25 Crore, with operations targeted by March 2027.
- Value
- ₹1.25 Cr
- Execution
- OPD and therapy centre operations from December 2026; full hospital operations by March 2027, subject to approvals.
- hospital beds
- 10.0 beds
Sat Kartar Life Other Announcement
Sat Kartar Life intends to voluntarily submit quarterly financial results from the quarter ending December 31, 2026, in addition to half-yearly results. No financial figures are disclosed.
Sat Kartar Life Convertible Warrants
Sat Kartar Life allotted 5,50,000 convertible warrants to promoter-category allottees at ₹172 each on a preferential basis. The issue totals ₹9.46 Crore, with 25% already received.
- Value
- ₹9.46 Cr
- Execution
- Conversion within 18 months from allotment, lapsing by 15 May 2028
Sat Kartar Life Capacity Expansion: ₹0.75 Cr Investment
Sat Kartar Life proposes a new 15-bed Ayurveda hospital and wellness centre in Ludhiana, Punjab, with an estimated investment of ₹75 lakh. It is expected to be operational by March 2027, subject to approvals.
- Value
- ₹0.75 Cr
- Execution
- Expected to be operational by March 2027, subject to approvals and operational readiness
- hospital beds
- 15.0 beds
Sat Kartar Life Capacity Expansion: ₹1.25 Cr Investment
Sat Kartar Life proposes a 30-bed Ayurveda hospital in Jaipur at an estimated ₹1.25 Crore investment. The facility is expected to be operational by March 2027.
- Value
- ₹1.25 Cr
- Ayurveda hospital beds
- 30 beds
Sat Kartar Life Convertible Warrants
Sat Kartar Life received NSE in-principle approval to list 5,50,000 equity shares from warrant conversion. Approval is subject to listing application and allottee undertakings.
Other business update announcements
All →Ritco Logistics Business Update
Ritco Logistics reported new transportation contract wins from ISRPL, Saint-Gobain and others in October 2026. The update also covers TrucksUp's monthly FASTag, financing, fuel and subscription metrics.
Permanent Magnets Business Update
Permanent Magnets' wholly owned subsidiary Quantum Magnetics will inaugurate its NdFeB permanent magnet plant in Vasai on 8 December 2026. The facility will serve EV, renewable energy and electronics applications.
Cohance Lifesciences Business Update
Cohance Lifesciences disclosed that USFDA issued the Establishment Inspection Report for its Shamshabad formulation facility, classifying the inspection as Voluntary Action Indicated (VAI). The inspection is now concluded.
Aurobindo Pharma Business Update
Aurobindo's subsidiary Apitoria's Unit-VI received a USFDA EIR classifying it as Voluntary Action Indicated, and the inspection is now closed. No monetary penalty is stated.
Freshara Agro Exports Business Update
Freshara Agro Exports received ASSOCHAM's 'Best Manufacturing - Export of the Year 2026' award on November 20, 2026. The award recognises growth in its export business.
Dev Accelerator Business Update
Dev Accelerator filed its October 2026 newsletter, recapping Q2 FY27 results and PALFINGER's Pune office inauguration. The revenue and EBITDA figures restate results already reported.